Shipping services continue despite COVID-19 outbreak ! Click here to view COVID-19 related products

Vemurafenib (PLX4032)

For research use only.

Catalog No.S1267 Synonyms: RG7204

453 publications

Vemurafenib (PLX4032) Chemical Structure

CAS No. 918504-65-1

Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM in cell-free assay. 10-fold selective for B-RafV600E over wild-type B-Raf in enzymatic assays and the cellular selectivity can exceed 100-fold. Vemurafenib (PLX4032, RG7204) induces autophagy.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 91 In stock
USD 70 In stock
USD 270 In stock
USD 770 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Vemurafenib (PLX4032) has been cited by 453 publications

Purity & Quality Control

Choose Selective Raf Inhibitors

Biological Activity

Description Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM in cell-free assay. 10-fold selective for B-RafV600E over wild-type B-Raf in enzymatic assays and the cellular selectivity can exceed 100-fold. Vemurafenib (PLX4032, RG7204) induces autophagy.
Features A novel and potent inhibitor of the B-RAFV600E oncoprotein.
Targets
SRMS [1]
(Cell-free assay)
ACK1 [1]
(Cell-free assay)
B-Raf (V600E) [1]
(Cell-free assay)
C-Raf [1]
(Cell-free assay)
MAP4K5 (KHS1) [1]
(Cell-free assay)
18 nM 19 nM 31 nM 48 nM 51 nM
In vitro

PLX4032 inhibits B-RAFV600E, C-RAF, as well as wildtype B-RAF, with IC50 of 31 nM, 48 nM and 100 nM, respectively. PLX4032 also inhibits several non-RAF kinases, including ACK1, KHS1, and SRMS, with IC50 of 18 nM to 51 nM. [1] In melanoma cell lines, the inhibitory effect by PLX4032 depends on B-RAF mutational status, because PLX4032 potently inhibits those harboring B-RAF V600 mutants, including V600E, V600D, V600K, and V600R, but not wildtype or other mutants. The IC50 values of PLX4032 on these cells, including MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058, ranges from 20 nM to 1 μM. In these cells, PLX4032 (0.1 μM to 30 μM) also inhibits the phosphorylation of both MEK1/2 and ERK1/2. [2] PLX4032 is highly effective in the treatment of melanoma, for its ability of inhibiting B-RAFV600E. However, PLX4032 displays limited effect in colon cancer patients that also carrying B-RAFV600E oncoprotein. The reason for this is that, in colon cancer cells, B-RAFV600E inhibition by PLX4032 results in a rapid feedback EGFR activation, which compensates for the PLX4032-inhibited cell proliferation. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SKMEL19 M{TCUGZ2dmO2aX;uJGF{e2G7 M3z6RlYh|ryP MVe0PEBp NIDqcmJFVVOR NHfBWHpVemmpZ3Xyd{BGWiC|dILld5M> MnvDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|NkKyOFAoRjJ|M{[yNlQxRC:jPh?=
VMM12 NWXuWZFSTnWwY4Tpc44hSXO|YYm= MmPLN{DPxE1? NWW1UVB7PDhiaB?= MYjEUXNQ NEnjcY5KdmO{ZXHz[ZMh[2:ubHHn[Y4he3mwdHjld4l{KGGwZDDk[YNz\WG|ZYOgTWwuQSCneIDy[ZN{cW:w M2jMVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OUi5OVA3Lz5{NUm4PVUxPjxxYU6=
C4 MWDGeY5kfGmxbjDBd5NigQ>? M33lclMh|ryP NEfOZ5o1QCCq NEW4NnFFVVOR M1;hOmlv[3KnYYPld{Bkd2yuYXflckB{gW62aHXzbZMh[W6mIHTlZ5Jm[XOnczDJUE05KGW6cILld5Nqd25? NYfJepRzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5PFk2ODZpPkK1PVg6PTB4PD;hQi=>
Calu-6 MoT6SpVv[3Srb36gRZN{[Xl? M4XqeVHjiIoQvF2= NIDLWZYyKGh? NV3TOIdCTE2VTx?= MYTBZ5RqfmG2ZYOgUWVMN0WUSzDpckBk\WyuczD3bZRpKHerbHSteJlx\SCEUlHG NFv1ZVY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEG3PVcxPSd-MkCxO|k4ODV:L3G+
PC MkDyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUK5OkBp NF7lUZVGSzVyPjCxNFAxKG6P MkDqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6OEC3PVIoRjF7OEiwO|kzRC:jPh?=
TPC-1 (RET/PTC1) MmHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\O[4I6PiCq NIHlR4RGSzVy4polNVAxOCCwTR?= NGDHXos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
CAL62 (KRAS G12R) > 1000 > 1000 MmLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFTWVXU6PiCq M4PCNGVEPTB-IEGwNFAhdk1? M1LYd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
HTH7 (NRAS Q61R) M4Dvemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWe5OkBp NYLwNXNNTUN3MPMJqUAyODByIH7N M3H5O|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
C643 (HRAS G13R)≥ 500 M1PIN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV:5OkBp MWrFR|UxKOLLpTC1NFAhdk1? MmC3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6OEC3PVIoRjF7OEiwO|kzRC:jPh?=
BCPAP (BRAF WT/V600E) M1jQc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTZWnc6PiCq MknESWM2OD15ODDuUS=> M{\tbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
BHT101 (BRAF WT/V600E) NEGxZWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHyPJI6PiCq M3P5VGVEPTB;OUegcm0> MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
SW1736 (BRAF WT/V600E) NWjMOXpbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjSPVYhcA>? MXrFR|UxRTJ7IH7N MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
8505C (BRAF V600E/V600E) MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUeweWNMQTZiaB?= MlPISWM2OD13NzDuUS=> MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
ARO NEDVUnpHfW6ldHnvckBCe3OjeR?= NWDqR|NPOTBizszN Mm[4O|IhcA>? MmfySG1UVw>? NIjHdJBKdmS3Y3XzJJRp\SC{ZXX4dJJme3Orb36gc4YhfGinIF7JV{BxfW2y MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR3OEC1N{c,OTh2NUiwOVM9N2F-
A375 M3rvdWFxd3C2b4Ppd{BCe3OjeR?= NWm2WJZ7OTBizszN MWLEUXNQ NVrNVG9wWHKxbX;0[ZMh[XCxcITveIlkKGSnYYTo NX7kNnVyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OVgxPTNpPkG4OFU5ODV|PD;hQi=>
TPCI MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvp[2UzOTByIN88US=> MU[5OkBp NGHifWJFVVOR M2XqdGlEPTB;MUCuO|ch|ryP NXjOdGNJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OVgxPTNpPkG4OFU5ODV|PD;hQi=>
ARO NGn5ZVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3LDNlExOCEQvF2= NGHMOlk6PiCq NXr1bpBQTE2VTx?= MnjmTWM2OD1{MEWgcm0> M3zwRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEW4NFU{Lz5zOES1PFA2OzxxYU6=
NPA MkfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2HHRVExOCEQvF2= NUXubJRWQTZiaB?= MmnPSG1UVw>? NULOd5d3UUN3ME2yOkBvVQ>? MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR3OEC1N{c,OTh2NUiwOVM9N2F-
A375 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2L4blExOCEQvF2= M37PfFk3KGh? M{fzb2ROW09? MorlTWM2OD12NzDuUS=> MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR3OEC1N{c,OTh2NUiwOVM9N2F-
UKF-NB-3 (ABCB1) NV\aTWNZTnWwY4Tpc44hSXO|YYm= M{C5XlEvOjViwsXN MoPZNkBp NXLSOY9oTE2VTx?= NWjLcXpWTW6qYX7j[ZMh[WOldX31cIF1cW:wIH;mJJRp\SCobIXvdoV{[2WwdDDBRmNDOSC|dXLzeJJifGVicnjv[IFucW6nIEGyNy=> NYntZ5MzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|U4PjZpPkK0O|M2PzZ4PD;hQi=>
UKF-NB-3 MWHGeY5kfGmxbjDBd5NigQ>? MnTwNU4zPSEEtV2= NX;lcG5{OiCq MV7EUXNQ MVHTbYdvcW[rY3HueIx6KGGoZnXjeJMhd25iYXPjeY12dGG2aX;uJI9nKHSqZTDmcJVwemW|Y3XueEBCSkOEMTDzeYJ{fHKjdHWgdohw\GGvaX7lJFEzOw>? NVX5cmQzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|U4PjZpPkK0O|M2PzZ4PD;hQi=>
A375 (BRAFV600E) M4LNVmZ2dmO2aX;uJGF{e2G7 M{PqcVghcA>? MlnVSG1UVw>? NXXPRopEUW6lcnXhd4V{KGmwdILhZ4VtdHWuYYKgVm9UKGGwZDDOU{Bt\X[nbIO= NGPI[Ig9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO2N|Y1PCd-MkWzOlM3PDR:L3G+
A375P M3Hr[WFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NFvPTXRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO|VRKGOnbHzzMEBKSzVyIE2gNE4zPTRizszNMi=> NYD1OoM3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OlAxOzBpPkKyOFYxODNyPD;hQi=>
A375 Mm\yRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MXnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{WgZ4VtdHNiZYjwdoV{e2mwZzDCMXJi\iCYNkCwSUBufXSjboSgZY5lKHerbHSgeJlx\SCUYYOsJGlEPTBiPTCwMlMyKM7:TT6= M3\ZbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEC4PVEyLz5{MkiwPFkyOTxxYU6=
A375P NGjHfFlCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NEPGS4M1QCCqcoO= MUjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{XQJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkK1JO69VS5? NFL4eHY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEGyPFQyOCd-MkSxNlg1OTB:L3G+
A375 NEjTXIdEgXSxdH;4bYNqfHliYYPzZZk> MXW3NkBpenN? NV;XdlFSS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTN5NTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5zODFOwG0v NIX5[|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEKxOVgyQCd-MkSyNVU5OTh:L3G+
SK-MEL-28 NXL1e2o4S3m2b4TvfIlkcXS7IHHzd4F6 M1;mWWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD2yPEBk\WyuczDlfJBz\XO|aX7nJGIuemGoIG[2NFBGKG23dHHueEwhUUN3MDC9JFAvOSEQvF2u MnjuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M229 NVn0UYUyS3m2b4TvfIlkcXS7IHHzd4F6 M4jBdGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG0zOjliY3XscJMh\XiycnXzd4lv\yCELYLh[kBXPjByRTDteZRidnRuIFnDOVAhRSByLkGg{txONg>? M4PuelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEexOFY3Lz5{NES3NVQ3PjxxYU6=
M263 NHO0ZoFEgXSxdH;4bYNqfHliYYPzZZk> NUf3O4lsS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVTJ4MzDj[YxteyCneIDy[ZN{cW6pIFKtdoFnKFZ4MEDFJI12fGGwdDygTWM2OCB;IECuNUDPxE1w NGHoR4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES3NVQ3Pid-MkS0O|E1PjZ:L3G+
M321 NGnXWmJEgXSxdH;4bYNqfHliYYPzZZk> NUC5XVF6S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVTN{MTDj[YxteyCneIDy[ZN{cW6pIFKtdoFnKFZ4MEDFJI12fGGwdDygTWM2OCB;IECuNUDPxE1w MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
M238 MmHrR5l1d3SxeHnjbZR6KGG|c3H5 MXLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlM5KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4> NWflVpJpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0O|E1PjZpPkK0OFcyPDZ4PD;hQi=>
M262 M2HnRmN6fG:2b4jpZ4l1gSCjc4PhfS=> MmrGR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUVI3OiClZXzsd{BmgHC{ZYPzbY5oKEJvcnHmJHY3ODCHIH31eIFvfCxiSVO1NEA:KDBwMTFOwG0v MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
M249 MYTDfZRwfG:6aXPpeJkh[XO|YYm= MUnDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlQ6KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4> MoLrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M14 M3vWWWN6fG:2b4jpZ4l1gSCjc4PhfS=> MVrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNVQh[2WubIOg[ZhxemW|c3nu[{BPWkGVIFexNmMhdXW2YX70MEBKSzVyIE2gNE4yPSEQvF2u MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
SK-MEL-28 MkHrRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MWi2PEBpenN? NV74eVMzSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvMkigZ4VtdHNiaHHyZo9zcW6pIFLSRWYhXjZyMFWgcZV1[W62IHHmeIVzKDZ6IHjyd{BjgSCPVGOgZZN{[XluIFnDOVAhRSByLkS4JO69VS5? MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDV6OEC3N{c,OjR3OEiwO|M9N2F-
insect cell NFXDXohHfW6ldHnvckBie3OjeR?= MnL2OlAhdWmwcx?= MmPjTY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiCELWLh[kBXPjByRTDteZRidnRiZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{KGmwZnXjeIVlKGmwc3XjeEBk\WyuczDhd5Nme3OnZDDhd{Bc\2GvbXGtN|NRZWmwY3;ydI9z[XSrb36gbY51dyCPRVugZYZ1\XJiNkCgcYlveyCkeTDzZ4lvfGmubHH0bY9vKGOxdX70bY5oNCCLQ{WwJF0hOC5yM{Gg{txONg>? M{DPfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwN|E2Lz5{NEmwNFMyPTxxYU6=
MALME-3M NUjUUFg4TnWwY4Tpc44h[XO|YYm= MoDINUBpeg>? NVLEbWpVUW6qaXLpeIlwdiCxZjDCMXJi\iCYNkCwSUBufXSjboStcYVlcWG2ZXSgSZJsKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBOSUyPRT2zUUBk\WyuczDh[pRmeiBzIHjyJIJ6KG[udX;y[ZNk\W6lZTDhcoFtgXOrczygTWM2OCB;IECuNFYyKM7:TT6= MmLMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECzNVUoRjJ2OUCwN|E2RC:jPh?=
A375 Ml;LSpVv[3Srb36gZZN{[Xl? M{XVO|EhcHJ? NX71W|d7UW6qaXLpeIlwdiCxZjDCMXJi\iCYNkCwSUBufXSjboStcYVlcWG2ZXSgSZJsKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBCOzd3IHPlcIx{KGGodHXyJFEhcHJiYomg[ox2d3Knc3PlcoNmKGGwYXz5d4l{NCCLQ{WwJF0hOC5zOTFOwG0v NVm4TplYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OTVpPkK0PVAxOzF3PD;hQi=>
COLO205 M3jhTmN6fG:2b4jpZ4l1gSCjc4PhfS=> MlTGOEBl[Xm| MnrzR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gR29NVzJyNTDj[YxteyCjZoTldkA1KGSjeYOgZpkhS2WubGTpeIVzNUeubzDhd5NigSxiRVO1NEA:KDBwMkSg{txONg>? MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOxOUc,OjR7MECzNVU9N2F-
WM266.4 MWDBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NVLaW|VVPDhiaILz NX7neopOSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDXUVI3Pi52IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB4IN88UU4> Ml7PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{NkewNFYoRjJ3Mk[3NFA3RC:jPh?=
A375 NE\5c3RCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NXXzW|NCPDhiaILz NFG5eoNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO|Uh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNVkh|ryPLh?= M1mxTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Mk[3NFA3Lz5{NUK2O|AxPjxxYU6=
WM1361 NHHiW5JCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MnL3OFghcHK| M{DkSGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iV12xN|YyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCxMlg4KM7:TT6= MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJ4N{CwOkc,OjV{NkewNFY9N2F-
A375 NYH3dZM3TnWwY4Tpc44h[XO|YYm= NVy3XHlxUW6qaXLpeIlwdiCxZjDCMZJi\iCYNkCwSUBufXSjboSgbY4hcHWvYX6gRVM4PSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gSXJMOS9{IIDoc5NxcG:{eXzheIlwdiCrbnP1ZoF1\WRiZn;yJFkxKG2rboOgZpkhX2W|dHXyckBjdG:2dHnu[{Bu\XSqb3SsJGlEPTBiPTCwMlA{OzFizszNMi=> NETkV|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS2NlI3Pyd-MkW0OlIzPjd:L3G+
A375 MmPxRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NYXw[FVDPzJiaILz MlXpRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDM{e1JINmdGy|IHHmeIVzKDd{IHjyd{BjgSCFQ1u4JIF{e2G7LDDJR|UxKD1iMz6zNVUh|ryPLh?= Mnv0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkKyOlcoRjJ3NE[yNlY4RC:jPh?=
SK-MEL-2 NGnw[VRHfW6ldHnvckBie3OjeR?= M2faXmlvcGmkaYTpc44hd2Zid3ns[EB1gXCnIFKtdoFnKGmwIHj1cYFvKFONLV3FUE0zKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDFVmsyNzJicHjvd5Bpd3K7bHH0bY9vKGmwY4XiZZRm\CCob4KgPVAhdWmwczDifUBY\XO2ZYLuJIJtd3S2aX7nJI1mfGixZB?= MnLyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkKyOlcoRjJ3NE[yNlY4RC:jPh?=
A375 M2r3T2Z2dmO2aX;uJIF{e2G7 MX[3NkBpenN? NI\sOFNKdmirYnn0bY9vKG:oIFLSRWYhXjZyMFWgcZV1[W62IHnuJIh2dWGwIFGzO|Uh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDFVmsheGixc4Doc5J6dGG2aX;uJI1m[XO3cnXkJIFnfGW{IEeyJIhzeyCkeTDFUGlUSSCjc4PhfUwhUUN3MDC9JFAvOTVizszNMi=> MkPCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7NkW4NFQoRjJ3OU[1PFA1RC:jPh?=
A375 NUfkTJExSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NWroV2o5PzJiaILz M3zKVWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OUBk\WyuczDh[pRmeiB5MjDodpMh[nlicnXzZZp2emmwIHHzd4F6NCCLQ{WwJF0hOC5zNzFOwG0v NIrEPG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm2OVgxPCd-MkW5OlU5ODR:L3G+
A375 MVzGeY5kfGmxbjDhd5NigQ>? NYGzdHp4OTVibXnudy=> MoXSR49ueGW2aYTpeoUh[mmwZHnu[{Bi\m[rbnn0fUB1dyCEUlHGJIlvKGi3bXHuJGE{PzViY3XscJMh[W[2ZYKgNVUhdWmwczDpckBxemW|ZX7j[UBw\iCDVGCgZY5idG:pdXWsJGlEPTBiPTCwMlI3KM7:TT6= MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl4NUiwOEc,OjV7NkW4NFQ9N2F-
A375 M2rS[GZ2dmO2aX;uJIF{e2G7 NHWxVlMyPSCvaX7z MmDYR49ueGW2aYTpeoUh[mmwZHnu[{Bi\m[rbnn0fUB1dyCDUlHGJIlvKGi3bXHuJGE{PzViY3XscJMh[W[2ZYKgNVUhdWmwczDpckBxemW|ZX7j[UBw\iCDVGCgZY5idG:pdXWsJGlEPTBiPTCwMlk2KM7:TT6= M{S5cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OU[1PFA1Lz5{NUm2OVgxPDxxYU6=
HCT116 NETWUoVHfW6ldHnvckBie3OjeR?= M3m0WGlvcGmkaYTpc44hd2ZiS2LBV{BIOTOGIH31eIFvfCCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDFVmsheGixc4Doc5J6dGG2aX;uJIJ6KEWOSWPBMEBKSzVyIE2gNVYvPiEQvF2u NW\yZodzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5OlU5ODRpPkK1PVY2QDB2PD;hQi=>
HCT116 MWTGeY5kfGmxbjDhd5NigQ>? NUH0eno3OC5|NDD0c{AzODByMDDuUS=> NGPveFdR[XKjZH;4bYNidCCjY4TpeoF1cW:wIH;mJHJCWy:UQV[vUWVMKHOrZ37hcIlv\yCyYYToe4F6KGmwIHj1cYFvKEiFVEGxOkBk\WyuczDlfJBz\XO|aX7nJJdqdGRidInw[UBDWkGIIHHzd4V{e2WmIHHzJGVTUyCyaH;zdIhwenmuYYTpc44h[XRiMD6zOEB1dyB{MECwNEBvVQ>? NI\6[449[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm2OVgxPCd-MkW5OlU5ODR:L3G+
NZM20 NVfLeW1kSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MU[2PEBpenN? MVzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE6cTUKwJINmdGy|IHX4dJJme3OrbnegRk1T[WZiVk[wNGUhdXW2YX70JIl{d2yjdHXkJIZzd21iTnX3JHpm[WyjbnSgcYV1[XO2YYTpZ{Bu\Wyjbn;tZUBx[XSrZX70JIlv[3WkYYTl[EBnd3JiNkigbJJ{KGK7IGPSRkBie3OjeTygTWM2OCB;IECuNFI1KM7:TT6= NETSfYc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
NZM07 MVzBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M3nWSFY5KGi{cx?= NFLad4VCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7aUVA4KGOnbHzzJIV5eHKnc4PpcochSi2UYX[gWlYxOEVibYX0ZY51KGm|b3zheIVlKG[{b32gUoV4KFqnYXzhcoQhdWW2YYP0ZZRq[yCvZXzhco9u[SCyYYTp[Y51KGmwY4XiZZRm\CCob4KgOlghcHK|IHL5JHNTSiCjc4PhfUwhUUN3MDC9JFAvODN4IN88UU4> MkTOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMEW1N|AoRjJ4MEC1OVMxRC:jPh?=
A375 M4PMOWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NYLBZoZ3PjhiaILz MXzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{WgZ4VtdHNiZYjwdoV{e2mwZzDCMXJi\iCYNkCwSUBufXSjboSgbY5kfWKjdHXkJIZweiB4ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMD6wO|kh|ryPLh?= MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjByNUWzNEc,OjZyMEW1N|A9N2F-
COLO205 NGH0dVlCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MlnBOlghcHK| NV7qS49DSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDU2xQOjB3IHPlcIx{KGW6cILld5NqdmdiQj3SZYYhXjZyMFWgcZV1[W62IHnuZ5Vj[XSnZDDmc5IhPjhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwM{C5JO69VS5? M1Tk[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
SK-MEL-28 MmK5RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NV7JTFNxPjhiaILz NHzKVWRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW1GVC1{ODDj[YxteyCneIDy[ZN{cW6pIFKtVoFnKFZ4MEDFJI12fGGwdDDpcoN2[mG2ZXSg[o9zKDZ6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkO4NUDPxE1w MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjByNUWzNEc,OjZyMEW1N|A9N2F-
HT-29 NH;ObVdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MmjmOlghcHK| M{n6NmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGStNlkh[2WubIOg[ZhxemW|c3nu[{BDNVKjZjDWOlAxTSCvdYThcpQhcW6ldXLheIVlKG[xcjC2PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE43ODFizszNMi=> Mm\jQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMEW1N|AoRjJ4MEC1OVMxRC:jPh?=
SK-MEL-1 MVrBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M3uycFY5KGi{cx?= NGnkcG1CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW1GVC1zIHPlcIx{KGW6cILld5NqdmdiQj3SZYYhXjZyMFWgcZV1[W62IHnuZ5Vj[XSnZDDmc5IhPjhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDFwNEm5JO69VS5? NGrDNmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
NZM40 Mo\TRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MmfrOlghcHK| MY\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE6cTUSwJINmdGy|IHX4dJJme3Orbnege4lt\CC2eYDlJGIuWmGoIHnzc4xifGWmIH\yc40hVmW5IGrlZYxidmRibXX0ZZN1[XSrYzDt[Yxidm:vYTDwZZRq\W62IHnuZ5Vj[XSnZDDmc5IhPjhiaILzJIJ6KFOUQjDhd5NigSxiSVO1NEA:KDNwMEGg{txONg>? NVjNbohWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[wNFU2OzBpPkK2NFA2PTNyPD;hQi=>
NZM09 M{nR[mFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NGPSNJI3QCCqcoO= MnjsRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCQWl2wPUBk\WyuczDlfJBz\XO|aX7nJJdqdGRidInw[UBDNVKjZjDpd49t[XSnZDDmdo9uKE6ndzDa[YFt[W6mIH3leIF{fGG2aXOgcYVt[W6xbXGgdIF1cWWwdDDpcoN2[mG2ZXSg[o9zKDZ6IHjyd{BjgSCVUlKgZZN{[XluIFnDOVAhRSB6LkOzJO69VS5? NXvn[4VWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[wNFU2OzBpPkK2NFA2PTNyPD;hQi=>
A375P NUXjb5luSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NUHDbpZqPzJiaILz NH\xRoZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO|VRKGOnbHzzJIV5eHKnc4PpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JGNmdGyWaYTldk1IdG9iYYPzZZktKEmFNUCgQUAxNjN5IN88UU4> MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjd{NEezNEc,OjZ5MkS3N|A9N2F-
BL21(DE3) MnL6SpVv[3Srb36gZZN{[Xl? M1;NTWlvcGmkaYTpc44hd2ZiTj30[ZJucW6jbDDobZMufGGpZ3XkJGJTSUZiVk[wNGUhdXW2YX70JEg1PDhidH:gO|I{KHKnc3nkeYV{MSBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDFd4Np\XKrY3jpZUBkd2yrIFLMNlEpTEV|KTDj[YxteyCjc4Pld5Nm\CCjczDwbI9{eGixconsZZRqd25ib3[gZolwfGmweXzheIVlNU2HSzDifUBCdHCqYWPjdoVmdiCjc4PhfUwhUUN3MDC9JFAvODNzIN88UU4> NGLZ[4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nki1NlYzOyd-Mk[4OVI3OjN:L3G+
A375 NYnXeIxkTnWwY4Tpc44h[XO|YYm= MVqxJIhz MWnJcohq[mm2aX;uJI9nKEJvUnHmJHY3ODCHIH31eIFvfCCrbjDoeY1idiCDM{e1JINmdGy|IHHzd4V{e2WmIHHzJGVTUyCyaH;zdIhwenmuYYTpc44heHKnaX7jeYJifGWmIH\vdkAyKGi{IHL5JHdme3Sncn6gZoxwfCCvZYToc4QtKEmFNUCgQUAxNjBzNzFOwG0v NFSyPJM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{C4OVY4Oid-MkewPFU3PzJ:L3G+
MIAPaCa2 MmjUSpVv[3Srb36gZZN{[Xl? NFWxT5cyKGi{ NVPZV2NzUW6qaXLpeIlwdiCxZjD3bYxlKHS7cHWgRk1T[WZiaX6gbJVu[W5iTVnBVIFE[TJiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJGVTUyCyaH;zdIhwenmuYYTpc44heHKnaX7jeYJifGWmIH\vdkAyKGi{IHL5JHdme3Sncn6gZoxwfCCvZYToc4QtKEWFNUCgQUAzNjJ7IN88UU4> MkW4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyOEW2O|IoRjJ5MEi1OlczRC:jPh?=
COLO205 MWHDfZRwfG:6aXPpeJkh[XO|YYm= NGe2R5Q4OiCqcoO= M3;ZUmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGNQVE9{MEWgZ4VtdHNiaHHyZo9zcW6pIFKtVoFnKFZ4MEDFJI12fGGwdDDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckBi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE4xPDRizszNMi=> NUC2W|FPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkexOVU5QTlpPkK3NVU2QDl7PD;hQi=>
HT-29 MmrzR5l1d3SxeHnjbZR6KGG|c3H5 MVO3NkBpenN? M{\ydGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhVNTJ7IHPlcIx{KGijcnLvdolv\yCELWLh[kBXPjByRTDteZRidnRiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNVU3KM7:TT6= NF\PRm09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{G1OVg6QSd-MkexOVU5QTl:L3G+
HCT116 NVXwbm1[S3m2b4TvfIlkcXS7IHHzd4F6 MnHRO|IhcHK| MUfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMhcGG{Yn;ybY5oKHerbHSgeJlx\SCELWLh[kBie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTRwNUig{txONg>? NHG2d2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{G1OVg6QSd-MkexOVU5QTl:L3G+
WM266.4 MlvVRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M1HWZ|I1KGi{cx?= NVzhWpl3SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDXUVI3Pi52IHPlcIx{KGG|c3Xzd4VlKGG|IHPlcIwhfmmjYnnsbZR6KGGodHXyJFI1KGi{czDifUBOXFRiYYPzZZktKEeLNUCgQUAxNjJzIN88UU4> Mo\nQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd{M{i4OFEoRjJ5MkO4PFQyRC:jPh?=
WM266.4 NE\sSopCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MWeyOEBpenN? MmHLRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCZTUK2Ok41KGOnbHzzJIhiemKxcnnu[{BDWkGIIG[2NFBGKG23dHHueEBie3Onc4Pl[EBieyClZXzsJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlA4KM7:TT6= MmfvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4M{SxPVUoRjJ5NkO0NVk2RC:jPh?=
A375 MXfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NHzwWWMzPCCqcoO= M{LZUGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OUBk\WyuczDhd5Nme3OnZDDhd{Bk\WyuIHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkKxJO69VS5? M4Dvc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkO0NVk2Lz5{N{[zOFE6PTxxYU6=
WM1361 NYD4S2F4SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MXiyOEBpenN? NYG3fJdiSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDXUVE{PjFiY3XscJMh[XO|ZYPz[YQh[XNiY3XscEBoem:5dHigbY5pcWKrdHnvckBi\nSncjCyOEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNU45PiEQvF2u NX3XfW5ZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2N|QyQTVpPkK3OlM1OTl3PD;hQi=>
SK-MEL-28 M3zyN2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 NELUXJk1QCCqcoO= MUXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONLV3FUE0zQCClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[XO|ZYPz[YQh[XNiY3;uZ4VvfHKjdHnvckBz\XG3aYLl[EBnd3JidH;0ZYwh\3Kxd4ToJIlvcGmkaYTpc44hdWWjc4Xy[YQh[W[2ZYKgOFghcHK|IILld4F7fXKrbjDhd5NigSxiVFfJJF0hOiEQvF2u MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzd5NEGzO{c,Ojd5N{SxN|c9N2F-
SK-MEL-28 MnHnS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NXT0RohjOSCqch?= MmXhS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gV2suVUWOLUK4JINmdGy|IHjhdoJwemmwZzDCVmFHKFZ4MEDFJI12fGGwdDDwdoVqdmO3YnH0[YQh\m:{IEGgbJIh\m:ubH;3[YQh[nliaYLyZYRq[XSrb36gc4YhOS5zMzDrW{9uOiCXVj3sbYdpfCCob4KgOUBucW6|IH3lZZN2emWmIHHmeIVzKDR6IHjyd{Bz\XOjeoXybY4h[XO|YYm= MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzd5NEGzO{c,Ojd5N{SxN|c9N2F-
A375 MoHkRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NWLZfW45PzJiaILz NHKxNXRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBpfW2jbjDBN|c2KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDj[YxtKHSrdHXyMYdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkeg{txONg>? MkPLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NEK1OVMoRjJ6MkSyOVU{RC:jPh?=
COLO205 NVX1ZYg5SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NXS2[nNJPzJiaILz M1zZ[WFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIh2dWGwIFPPUG8zODViY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxidHn0[ZIu\2yxIHz1cYlv\XOlZX7j[UBie3OjeTygTWM2OCB;IEWuNVYh|ryPLh?= MnThQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NEK1OVMoRjJ6MkSyOVU{RC:jPh?=
HepG2 M4jLXWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MUO3NkBpenN? NF;rNnhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjC3NkBpenNiYomgZ4VtdCC2aYTldk1odG9ibIXtbY5me2OnbnPlJIF{e2G7LDDJR|UxKD1iNT60PEDPxE1w NWXrV2hpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyOFI2PTNpPkK4NlQzPTV|PD;hQi=>
SK-MEL-2 NUjUbHU{SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MVS3NkBpenN? MnTqRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgbJVu[W5iU1utUWVNNTJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxidHn0[ZIu\2yxIHz1cYlv\XOlZX7j[UBie3OjeTygTWM2OCB;IEWuOlQh|ryPLh?= MmS2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NEK1OVMoRjJ6MkSyOVU{RC:jPh?=
K562 MlPSSpVv[3Srb36gZZN{[Xl? MWGxJIhz M2T2RXN1[WKrbHn6ZZRqd25ib3[gRnJCTiCrbjDoeY1idiCNNU[yJINmdGy|IHHmeIVzKDFiaIKgZpkhfGincn3hcEB{cGmodDDhd5NigSxiRVO1NEA:KDBwN{m0N|Mh|ryPLh?= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ6MEK2NUc,Ojh{OECyOlE9N2F-
K562 M3ntbWZ2dmO2aX;uJIF{e2G7 NWLUdIVzOSCqch?= NIHL[JVUfGGkaXzpfoF1cW:wIH;mJGZGS0hiaX6gbJVu[W5iS{W2NkBk\WyuczDh[pRmeiBzIHjyJIJ6KHSqZYLtZYwhe2irZoSgZZN{[XluIFXDOVAhRSB3LkCxNVg4KM7:TT6= NX\oSWhjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyPFAzPjFpPkK4NlgxOjZzPD;hQi=>
A375M MlrSRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MX63NkBpenN? MWnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{XNJINmdGy|IHjhdoJwemmwZzDCVmFHKFZ4MEDFJI12fGGwdDDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMD61JO69VS5? NFi1dVI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES1PFE{PCd-Mki0OVgyOzR:L3G+
1205 Lu M3r3NGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NYTkWZNsPzJiaILz M4TJSmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iMUKwOUBNfSClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFIh|ryPLh?= NEnCZWQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES1PFE{PCd-Mki0OVgyOzR:L3G+
A375M NFHv[JZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MmD1OFghcHK| NWLVOVR2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2VSClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFIvODVizszNMi=> M37PcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
UACC-903 M4TYXmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 Mne4O|IhcHK| NWHLSGY6SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDVRWNENTlyMzDj[YxteyCqYYLic5JqdmdiQmLBSkBXPjByRTDteZRidnRiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDJwNzFOwG0v MnvYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN|QoRjJ6NEW4NVM1RC:jPh?=
1205 Lu MX\BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NFPYXVU1QCCqcoO= M13EVWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iMUKwOUBNfSClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFcvPiEQvF2u Moe1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN|QoRjJ6NEW4NVM1RC:jPh?=
UACC-903 NELVVWNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MoXjOFghcHK| M2PT[mFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVVHDR{06ODNiY3XscJMhcGG{Yn;ybY5oKEKUQV[gWlYxOEVibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyOi5|IN88UU4> M2fVXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
CHL-1 MXHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MkjCO|IhcHK| MnfERY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFSFytNUBk\WyuczDoZZJjd3Krbnege4lt\CC2eYDlJGJTSUZiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDF{Lkeg{txONg>? M3XoWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
CHL-1 NEXVRopCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWP0U5pPPDhiaILz M{PEUGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1jMMVEh[2WubIOgbIFz[m:{aX7nJJdqdGRidInw[UBDWkGIIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB{MDFOwG0v NVLBTHF3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki0OVgyOzRpPkK4OFU5OTN2PD;hQi=>
HCT116 MWrGeY5kfGmxbjDhd5NigQ>? NH;JWXRUfGmvdXzheIlwdiCxZjDCVmFHNUOUQV[g[Ilu\XKrenH0bY9vKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDifUBtfWOrZnXyZZNmKGOxbYDs[Y1mdnSjdHnvckBie3OjeTygSWM2OCB;IECuOlAyKM7:TT6= Mn71QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3NUe0OVgoRjJ6NUW3OFU5RC:jPh?=
Calu6 MWHGeY5kfGmxbjDhd5NigQ>? M3PXc|MhfU1? M4DsRVIhcHK| NYXyT5RDSWO2aY\heIlwdiCxZjDDVmFHKGmwIHj1cYFvKEOjbIW2JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKE2HSzDwbI9{eGixconsZZRqd25iYYSgN{B2VSCjZoTldkAzKGi{czDifUBHWkWWIHHzd4F6 M{O1ZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUW3OFU5Lz5{OEW1O|Q2QDxxYU6=
Sf9 M2TzNGZ2dmO2aX;uJIF{e2G7 M4PkUlEhcHJ? MoHITY5pcWKrdHnvckBw\iCqdX3hckBbSUtiKEWgeI8hOzB7IILld4llfWW|KTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiU3[5JIlve2WldDDj[YxteyC3c3nu[{BbSUu2aXTlJIF{KHO3YoP0doF1\SCjZoTldkAyKGi{IHL5JI1ie3Nic4DlZ5Rzd22ndIL5MEBKSzVyIE2gNE4xOjNizszNMi=> MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDV6NkKxNUc,Ojh3OE[yNVE9N2F-
Sf9 MYnGeY5kfGmxbjDhd5NigQ>? MXGzNEBucW6| MWPJcohq[mm2aX;uJI9nKE5vdHXycYlv[WxiR2PUMZRi\2enZDDy[YNwdWKrbnHueEBpfW2jbjDmeYxtNWynbnf0bEBbSUtiZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{KGmwZnXjeIVlKFOoOTDpcpNm[3RiY3XscJMhfXOrbnegUWJRKGG|IIP1ZpN1emG2ZTDh[pRmeiB|MDDtbY5{KGK7IFHEVE1IdG9iYYPzZZktKEmFNUCgQUAxNjB|MUSg{txONg>? NV\aT41zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki1PFYzOTFpPkK4OVg3OjFzPD;hQi=>
UACC-903 NV[2fmNoS3m2b4TvfIlkcXS7IHHzd4F6 MVuyOUB2VQ>? MoLqOFghcHK| Ml[xR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gWWFESy17MEOgZ4VtdHNiYYPz[ZN{\WRiYYOgZ4VtdCC4aXHibYxqfHliYYSgNlUhfU1iYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSC{ZXzheIl3\SC2bzDjc451em:uLDDJR|UxKD1iMz62JO69VS5? NV\aT2hqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxN|MxOzVpPkK5NVM{ODN3PD;hQi=>
CHL-1 NF20OGNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M4L4Z|czKGi{cx?= NVXTNndsSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDTGwuOSClZXzsd{Bp[XKkb4Lpcochf2muZDD0fZBmKEKUQV[gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGzMlch|ryPLh?= NXnTeG1uRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxN|MxOzVpPkK5NVM{ODN3PD;hQi=>
A375 M{POPGZ2dmO2aX;uJIF{e2G7 M1HFVlk3KGi{cx?= MnfLTY5pcWKrdHnvckBw\iCEUlHGJHY3ODCHIH31eIFvfCCrbjDoeY1idiCDM{e1JINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiClZXzsJJBzd2yrZnXyZZRqd25iaX7jeYJifGWmIH\vdkA6PiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5zMkeg{txONg>? NVLlcYRjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0NFc6PzdpPkK5OFA4QTd5PD;hQi=>
A375 NYnBS|Q5TnWwY4Tpc44h[XO|YYm= NHHKPHhKdmirYnn0bY9vKG:oIFLSRWYhXjZyMFWgcZV1[W62IHnuJIh2dWGwIFGzO|Uh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIFXST{BxcG:|cHjvdplt[XSrb36gZpkhSWyyaHHTZ5Jm\W5iYYPzZZktKEmFNUCgQUAxNjB|MjFOwG0v MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR4MUiyO{c,Ojl2NkG4Nlc9N2F-
SK-MEL-32 NIXuUVlEgXSxdH;4bYNqfHliYYPzZZk> MWTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvM{KgZ4VtdHNuIFnDOVAhRSByLkOxJO69VS5? M{LDOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NE[xPFI4Lz5{OUS2NVgzPzxxYU6=
WM266.4 NYHiOY9iSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MWe0PEBpenN? MmTBRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCZTUK2Ok41KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGdKPTBiPTCwMlIyKM7:TT6= MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MES2N{c,Ojl7NEC0OlM9N2F-
A375 NIPxUYNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NIjRN401QCCqcoO= MVvBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiR1m1NEA:KDBwOUWg{txONg>? NXLzd4hRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFA1PjNpPkK5PVQxPDZ|PD;hQi=>
HT-29 NGf1[VFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWDVOWs{PDhiaILz NEDwZWlCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUMVI6KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGdKPTBiPTCxMlg5KM7:TT6= NU[wUGt7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFA1PjNpPkK5PVQxPDZ|PD;hQi=>
WM1361 MnrURY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M1HITVQ5KGi{cx?= NGDEO2JCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGfNNVM3OSClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBIUTVyIE2gNlAvQCEQvF2u MkOyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEC0OlMoRjJ7OUSwOFY{RC:jPh?=
HCT116 NEHrfm5CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWfJenc5PDhiaILz M2XNXGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFPUNVE3KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGdKPTBiPTCyOU4zKM7:TT6= NGDSZnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFQ3Oyd-Mkm5OFA1PjN:L3G+
A673 NFX3XVhyUFSVIHHzd4F6 MXPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? MlnyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
DAOY M1nRbZFJXFNiYYPzZZk> MWDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhTEGRWTDj[Yxtew>? MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD M2DiXJFJXFNiYYPzZZk> MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWkRiY3XscJM> MkSzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-SH Mk\xdWhVWyCjc4PhfS=> NYHISGIxeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uW0hiY3XscJM> NEHueHA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) Ml73dWhVWyCjc4PhfS=> NW\sUW84eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF3HJFY{KCh4LWTHJHIqKGOnbHzz MmH1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB1643 NILkfmpyUFSVIHHzd4F6 NYDWc4RXeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CNVY1OyClZXzsdy=> M4XYfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 NYXaXJl[eUiWUzDhd5NigQ>? MWLxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy| NYfoOY9PRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
A673 NH7CfYNyUFSVIHHzd4F6 MUHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDBOlc{KGOnbHzzLS=> M2jiWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
U-2 OS NIXwPFRyUFSVIHHzd4F6 NX\VdoI1eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhXS1{IF;TJINmdGy| NUPM[mpvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh41 MorzdWhVWyCjc4PhfS=> MX;xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDSbFQyKGOnbHzz MlraQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 MYPxTHRUKGG|c3H5 M1HaZZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSj3HRm0zKGOnbHzz NELaOJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NVf2NZJJeUiWUzDhd5NigQ>? Mo\kdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tUWMh[2WubIO= M1fBfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5 NGDY[4NyUFSVIHHzd4F6 NUfv[JJweUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFzBUk02KGOnbHzz MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC NWLGUnZSeUiWUzDhd5NigQ>? NXLL[IFkeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= M2Kxe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
TC32 NETyR3ZyUFSVIHHzd4F6 MknCdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgWGM{OiClZXzsdy=> M1zBdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-ERK / p-CRAF; 

PubMed: 22448344     


BRAF mutant cell lines from (A) were treated with 3µM vemurafenib for the indicated times, and lysates were probed with the indicated antibodies.

p-MEK(S217/221) / pAKT(T308) / p-AKT(S473) / p-P70 S6K(T389) / p-S6(Ser235-236) / P-4EB-P1; 

PubMed: 22194965     


Western blot analysis of phosphorylated and the total amount of key proteins in the MAPK and PI3K/AKT pathways after 24 hours of exposure to the solvent (DMSO), or various concentrations of the BRAF inhibitor vemurafenib. The vemurafenib-sensitive M238 and M229 cell lines and the vemurafenib in vitro acquired resistant sublines M238-AR2 and M229-AR9 were cultured at different concentrations of vemurafenib. p70 and p-p70 S6K in this figure are referred to S6K1 and phosphorylated form of S6K1, respectively.

Bax / Bcl2 / Bcl-xl / BIM / Mcl1; 

PubMed: 28382170     


Change of Bcl-2 family proteins following Vemurafenib treatment for 24 h.

22448344 22194965 28382170
Growth inhibition assay
Cell viability; 

PubMed: 29179510     


At different time point of the experiment (expressed in days), sensitivity to vemurafenib was evaluated in the different A375 cell lines. Cells were treated with 10-fold dilution series (1 nM to 10 uM) of Vemurafenib and cell viability was assessed after 72 h by Crystal violet staining. Cell viability results are expressed in fold vs. the untreated cells.

29179510
Immunofluorescence
uPAR / α5-β1; 

PubMed: 30611716     


Representative images of confocal microscopy of companion M6R treated cultures stained with specific anti-uPAR (red), α5β1 (green) and DAPI (blue). Experiments have been performed three times in triplicate with analogous results. The co-localization score is quantified by image J andreported within each picture as Manders' coefficient (MC). The shown pictures are representative of 20 different pictures for each experimental condition. Scale bar = 20 μm.

p-Akt(Thr308); 

PubMed: 27293997     


Vemurafenib reduced phosphorylated Akt in HUVEC. Cells were treated with vemurafenib for 4 h and processed for immunofluorescence staining with antibodies against p-AktThr308. Cell nuclei were stained with DAPI. Scale bar represents 50 μm. 

30611716 27293997
In vivo In B-RAFV600E-mutant mice xenograft models, PLX4032 (6 mg/kg–20 mg/kg) inhibits tumor growth. [1] In mice xenograft models of LOX, Colo829, and A375 cells, PLX4032 (12.5 mg/kg–100 mg/kg) inhibits tumor growth and prolongs mice survival. [2]

Protocol

Kinase Assay:

[1]

- Collapse

RAF kinase activity measurements:

The kinase activities of wild-type RAF and mutants are determined by measuring phosphorylation of biotinylated-BAD protein. For each enzyme (0.01 ng), 20 μL reactions are carried out in 20 mM Hepes (pH 7.0), 10 mM MgCl2, 1 mM DTT, 0.01% (v/v) Tween-20, 50 nM biotin-BAD protein, and 1 mM ATP at room temperature. Reactions are stopped at 5 min with 5 μL of a solution containing 20 mM Hepes (pH 7.0), 200 mM NaCl, 80 mM EDTA, 0.3% (w/v) bovine serum albumin (BSA). The stop solution also includes phospho-BAD (Ser112) antibody, streptavidin-coated donor beads, and protein A acceptor beads. The antibody and beads are pre-incubated in stop solution in the dark at room temperature for 30 min. The final dilution of antibody is 1/2000 and the final concentration of each bead is 10 μg/mL. The assay plates are incubated at room temperature for one hour and then are read on a PerkinElmer AlphaQuest reader. Mutant activities are the average of two different batches of purified protein assayed in duplicate in three different experiments.
Cell Research:

[2]

- Collapse
  • Cell lines: MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058 cells
  • Concentrations: 0–10 μM , dissolved in DMSO
  • Incubation Time: 5 days
  • Method:

    Cellular proliferation is evaluated by MTT assay. Briefly, cells are plated in 96-well microtiter plates at a density of 1000 to 5000 cells per well in a volume of 180 μL. PLX4032 is prepared at 10 times the final assay concentration in media containing 1% DMSO. Twenty-four hours after cell plating, 20 μL of the appropriate dilution of PLX4032 are added to plates in duplicate. The plates are assayed for proliferation 6 days after the cells are plated. Percent inhibition is calculated and the IC50 is determined from the regression of a plot of the logarithm of the concentration versus percent inhibition.


    (Only for Reference)
Animal Research:

[2]

- Collapse
  • Animal Models: Mice (athymic nude) xenograft models of LOX, Colo829, and A375 cells
  • Dosages: 12.5 mg/kg–100 mg/kg
  • Administration: Oral gavage twice daily
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 97 mg/mL (197.99 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
4% DMSO+30% PEG 300+5% Tween 80+ddH2O (suspension)
For best results, use promptly after mixing.
5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 489.92
Formula

C23H18ClF2N3O3S

CAS No. 918504-65-1
Storage powder
in solvent
Synonyms RG7204
Smiles CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03410875 Recruiting Drug: Vemurafenib|Drug: Obinutuzumab Hairy Cell Leukemia|Leukemia|Leukemia Hairy Cell Memorial Sloan Kettering Cancer Center|Dana-Farber Cancer Institute|Yale University February 9 2018 Phase 2
NCT03013491 Active not recruiting Drug: CX-072|Drug: ipilimumab|Drug: vemurafenib Solid Tumor|Lymphoma CytomX Therapeutics January 2017 Phase 1|Phase 2
NCT02441465 Completed Drug: Vemurafenib|Drug: 14C-Labeled Vemurafenib Malignant Melanoma Cancer Hoffmann-La Roche August 13 2015 Phase 1
NCT02427893 Withdrawn Drug: Cobimetinib|Drug: Vemurafenib Melanoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Genentech Inc. August 2015 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How about the half-life of Vemurafenib(S1267)?

  • Answer:

    It was reported that the half-life of the compound is 57 hours.

  • Question 2:

    The vemurafenib power, when prepared in 4% DMSO/30% PEG 300/5% Tween 80/ddH2O solutions, form a pellet down the tube?

  • Answer:

    When prepare this kind of vehicle, please dissolve the drug in DMSO clearly first. If it dissolves not readily, please sonicate and warm in the water bath at about 45 degree. Then add PEG and Tween. After they mixed homogeneously, then dilute with water.

Raf Signaling Pathway Map

Raf Inhibitors with Unique Features

Related Raf Products

Tags: buy Vemurafenib (PLX4032) | Vemurafenib (PLX4032) supplier | purchase Vemurafenib (PLX4032) | Vemurafenib (PLX4032) cost | Vemurafenib (PLX4032) manufacturer | order Vemurafenib (PLX4032) | Vemurafenib (PLX4032) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID